Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
BridgeBio Oncology Therapeutics, Inc. - Common Stock
(NQ:
BBOT
)
13.12
+0.74 (+5.98%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
130,374
Open
12.61
Bid (Size)
12.50 (7,000)
Ask (Size)
13.88 (400)
Prev. Close
12.38
Today's Range
12.45 - 13.68
52wk Range
10.26 - 13.68
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
BBOT Reports Third Quarter 2025 Financial Results and Update on Corporate Progress
November 12, 2025
From
TheRas, Inc. (d/b/a BBOT)
Via
GlobeNewswire
BBOT to Participate in the Jefferies Global Healthcare Conference in London
November 03, 2025
From
TheRas, Inc. (d/b/a BBOT)
Via
GlobeNewswire
Performance
YTD
+5.5%
+5.5%
1 Month
+9.8%
+9.8%
3 Month
+5.5%
+5.5%
6 Month
+5.5%
+5.5%
1 Year
+5.5%
+5.5%
More News
Read More
BBOT Announces Poster Presentations at the San Antonio Breast Cancer Symposium (SABCS)
October 30, 2025
From
TheRas, Inc. (d/b/a BBOT)
Via
GlobeNewswire
Preclinical Data Presented at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Support Potential of BBO-10203, a First-in-Class RAS:PI3Kα Breaker That Inhibits KRAS-Mutant Tumor Growth without Inducing
October 25, 2025
From
TheRas, Inc. (d/b/a BBOT)
Via
GlobeNewswire
BBOT Presents Preclinical Data Demonstrating Potential of BBO-11818 as a Potent panKRAS Inhibitor at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 23, 2025
From
TheRas, Inc. (d/b/a BBOT)
Via
GlobeNewswire
BBOT Announces Poster Presentations at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 13, 2025
From
TheRas, Inc. (d/b/a BBOT)
Via
GlobeNewswire
Frequently Asked Questions
Is BridgeBio Oncology Therapeutics, Inc. - Common Stock publicly traded?
Yes, BridgeBio Oncology Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does BridgeBio Oncology Therapeutics, Inc. - Common Stock trade on?
BridgeBio Oncology Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for BridgeBio Oncology Therapeutics, Inc. - Common Stock?
The ticker symbol for BridgeBio Oncology Therapeutics, Inc. - Common Stock is BBOT on the Nasdaq Stock Market
What is the current price of BridgeBio Oncology Therapeutics, Inc. - Common Stock?
The current price of BridgeBio Oncology Therapeutics, Inc. - Common Stock is 13.12
When was BridgeBio Oncology Therapeutics, Inc. - Common Stock last traded?
The last trade of BridgeBio Oncology Therapeutics, Inc. - Common Stock was at 11/14/25 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.